Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein regulatory complex subunit 11 like (DRC11L) is a protein-coding gene that belongs to a poorly characterized class of proteins containing IQ motifs and AAA (ATPases Associated with diverse cellular Activities) domains. It is predicted to have ATP hydrolysis and microtubule-severing ATPase activities and is involved in microtubule cytoskeleton organization. Clinical associations (predicted, not firmly established) include infantile hypophosphatasia and SAPHO syndrome. DRC11L is not currently recognized as a direct therapeutic target, and validated drugs or biomarker roles have not been described. Nomenclature ambiguity and limited functional data suggest that the knowledge about this target is incomplete and potentially contains pseudogene annotations or confounding aliases[3]. Key issues: DRC11L refers to a predicted/poorly characterized gene/protein, with confounding aliases and references to pseudogenes. There is no evidence that this is a validated therapeutic target or that it is commonly targeted in drug discovery. The function and clinical significance are predicted/computational and not deeply experimentally validated[3]. If highly structured, validated information is needed for drug development or biomarker studies, the incompleteness and the pseudogene status of some aliases indicate that caution is required in using this target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein regulatory complex subunit 11 like (DRC11L).